These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14890764)

  • 21. Pyretogenic effect of lysergic acid diethylamide.
    HORITA A; DILLE JM
    Science; 1954 Dec; 120(3131):1100-1. PubMed ID: 13216227
    [No Abstract]   [Full Text] [Related]  

  • 22. Some central effects of lysergic acid diethylamide on vasomotor responses.
    GINZEL KH
    J Physiol; 1955 Sep; 129(3):61-2P. PubMed ID: 13264150
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on the mechanism of lysergic acid diethylamide. I].
    ARNOLD OH; HOFF H
    Wien Z Nervenheilkd Grenzgeb; 1953; 6(2-3):129-50. PubMed ID: 13078602
    [No Abstract]   [Full Text] [Related]  

  • 24. Tolerance to the pyretogenic effects of lysergic acid diethylamide.
    GOGERTY JH; DILLE JM
    J Pharmacol Exp Ther; 1956 Apr; 116(4):450-2. PubMed ID: 13320288
    [No Abstract]   [Full Text] [Related]  

  • 25. The effects of lysergic acid diethylamide on the excitability cycle of the lateral geniculate.
    EVARTS EV; MARSHALL WH
    Trans Am Neurol Assoc; 1955-1956; (80th Meeting):58-60. PubMed ID: 13312000
    [No Abstract]   [Full Text] [Related]  

  • 26. Possible biosynthesis of D-lysergic acid diethylamide-like compounds from mescaline.
    FISCHER R
    Experientia; 1955 Apr; 11(4):162-3. PubMed ID: 14380263
    [No Abstract]   [Full Text] [Related]  

  • 27. Progression of effects of lysergic acid diethylamide (LSD).
    SALVATORE S; HYDE RW
    AMA Arch Neurol Psychiatry; 1956 Jul; 76(1):50-9. PubMed ID: 13338909
    [No Abstract]   [Full Text] [Related]  

  • 28. Some effects of bufotenine and lysergic acid diethylamide on the monkey.
    EVARTS EV
    AMA Arch Neurol Psychiatry; 1956 Jan; 75(1):49-53. PubMed ID: 13275159
    [No Abstract]   [Full Text] [Related]  

  • 29. Mental changes experimentally produced by d-lysergic acid diethylamide tartrate.
    DeSHON HJ; RINKEL M; SOLOMON HC
    Psychiatr Q; 1952 Jan; 26(1):33-53. PubMed ID: 14920626
    [No Abstract]   [Full Text] [Related]  

  • 30. [Biosynthesis of ergot alkaloids. Biogenetic relationships between clavine and lysergic acid derivatives].
    Floss HG; Günther H; Gröger D; Erge D
    Z Naturforsch B; 1966 Feb; 21(2):128-31. PubMed ID: 4383174
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative subjective effects of seven drugs including lysergic acid diethylamide (LSD-25).
    JARVIK ME; ABRAMSON HA; HIRSCH MW
    J Abnorm Psychol; 1955 Nov; 51(3):657-62. PubMed ID: 13286016
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of lysergic acid diethylamide on Betta splendens. I.
    TURNER WJ
    Dis Nerv Syst; 1956 Jun; 17(6):193-7. PubMed ID: 13330611
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of lysergic acid diethylamide on circulatory reflexes].
    GINZEL KH
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 228(1-2):149-50. PubMed ID: 13334587
    [No Abstract]   [Full Text] [Related]  

  • 34. On some effects of lysergic acid diethylamide (L.S.D. 25) in normal volunteers.
    BRADLEY PB; ELKES C; ELKES J
    J Physiol; 1953 Aug; 121(2):50P-51P. PubMed ID: 13085360
    [No Abstract]   [Full Text] [Related]  

  • 35. Antagonism between lysergic acid diethylamide and 5-hydroxytryptamine.
    GADDUM JH
    J Physiol; 1953 Jul; 121(1):15P. PubMed ID: 13085323
    [No Abstract]   [Full Text] [Related]  

  • 36. New blocking agent against the development of LSD-25 psychosis.
    FABING HD
    Science; 1955 Feb; 121(3137):208-10. PubMed ID: 13237971
    [No Abstract]   [Full Text] [Related]  

  • 37. [THE LATEST FINDINGS IN THE FIELD OF ERGOT ALKALOIDS].
    HOFMANN A
    Dan Tidsskr Farm; 1963 Aug; 37():181-200. PubMed ID: 14049456
    [No Abstract]   [Full Text] [Related]  

  • 38. Distribution and fate of 14C-labeled lysergic acid diethylamide (LSD 25) in the animal body.
    STOLL A; ROTHLIN E; RUTSCHMANN J; SCHALCH WR
    Experientia; 1955 Oct; 11(10):396-7. PubMed ID: 13277462
    [No Abstract]   [Full Text] [Related]  

  • 39. Experimental compound mer-17 (frenquel): a new blocking agent against the development of LSD-25 psychosis.
    FABING HD
    Trans Am Neurol Assoc; 1955-1956; (80th Meeting):83-5. PubMed ID: 13312008
    [No Abstract]   [Full Text] [Related]  

  • 40. Brom-lysergic acid diethylamide: a highly potent serotonin antagonist.
    SOLLERO L; PAGE IH; SALMOIRAGHI GC
    J Pharmacol Exp Ther; 1956 May; 117(1):10-5. PubMed ID: 13320295
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.